EGCG down-regulated FAS by suppressing HER2 or/and HER3 signaling and downstream PI3K/Akt activation in the MCF-7 breast cancer cell line [32]; (5) Regulating NO/NOS system. Here, ERBB3 is linked to breast carcinoma.